Tag Archive for: Kurma Partners

European biotech is seeing both encouraging momentum and challenges. Innovation from European academia continues to inspire therapeutic concepts.

SciRhom management: Jens Ruhe, COO, Jan Poth, CEO, und Matthias Schneider, CSO. © SciRhom/ Paul Paulsen

German iRhom2-targeted antibody specialist SciRhom GmbH has closed an oversubscribed €63m Series A financing that will be used to provide clinical proof of concept in autoimmune disorders.